Monday, May 4, 2015
- 4:12pm-4:24pm
-
Evaluation of Donor-Specific Antibodies Through 7 Years With Belatacept in BENEFIT and BENEFIT-EXT
Concurrent Session: Kidney: Novel Agents • Terrace I-III
- 4:12pm-4:24pm
-
IL-21 Regulates Creation of Tertiary Lymphoid Organs in Chronic Allograft Rejection
Concurrent Session: T Cell Help and Alloimmunity • Room 118-C
- 4:12pm-4:24pm
-
Impact of Induction Therapy on Outcomes in HIV + Renal Transplant Recipients
Concurrent Session: Kidney: Induction • Room 120-ABC
- 4:12pm-4:24pm
-
Risk of Cause-Specific ESRD in Live Kidney Donors
Concurrent Session: Kidney: Living Donor Issues II • Terrace IV
- 4:12pm-4:24pm
-
Role of Innate Immune Cells in Chronic Allograft Loss and Novel Strategies to Target Them
- 4:12pm-4:24pm
-
Survival Benefit of Kidney Transplantation With Expanded Criteria Kidney from Donors After Circulatory Death
Concurrent Session: Kidney: KDPI and Non Ideal Kidneys • Room 118-AB
- «Previous Page
- 1
- …
- 10
- 11
- 12
- 13
- 14
- …
- 48
- Next Page»